FDA Approves 54 New Cancer Drugs Without Proof They Extend Life
The average chemotherapy cancer drug costs $10,000.00 per month, and only extends a patient’s life by an average of 42 days. (See: Doctors Expose Cancer Drugs Scandal.)
The Milwaukee Journal Sentinel is reporting that over the past 10 years, the FDA has approved 54 cancer drugs with no proof they are extending lives. They report that the FDA does not even require drug companies to prove their drugs extend lives:
Instead, the agency approved the drugs based on surrogate measures, such as a tumor shrinking, rather than the gold standard and most reliable measure of cancer research, patients actually surviving longer. The problem is cancer is complicated — a tumor might stop growing or shrink in one spot, then reappear somewhere else, or even in multiple places.
So just remember these facts the next time you take out your wallet or checkbook to donate money to your favorite cancer charity, which pays for the research for these worthless drugs.
The post FDA Approves 54 New Cancer Drugs Without Proof They Extend Life appeared first on Silver For The People.
